Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Heart Failure Reports
Published in: Current Heart Failure Reports 2/2014

01-06-2014 | Management of Heart Failure (TE Meyer, Section Editor)

Interventions for Heart Failure Readmissions: Successes and Failures

Authors: Lisa M. Fleming, Robb D. Kociol

Published in: Current Heart Failure Reports | Issue 2/2014

Login to get access

Abstract

Heart failure readmissions result in significant costs to the health care system and to patients’ quality of life, but programs to reduce readmissions have met with mixed success. Successful strategies have included multidisciplinary hospital-based quality initiatives, disease management programs, and care transition interventions. Devices like telemonitors and indwelling catheters, however, have met with mixed success. Research is still needed to elucidate the most effective interventions for readmission reduction in the HF population.
Literature
1.
Hall MJ, Levant S, DeFrances CJ. Hospitalization for congestive heart failure: United states, 2000-2010. NCHS Data Brief. 2012;(108):1–8.
2.
Shah RU, Tsai V, Klein L, Heidenreich PA. Characteristics and outcomes of very elderly patients after first hospitalization for heart failure. Circ Heart Fail. 2011;4(3):301–7.PubMedCrossRef
3.
Chen J, Ross JS, Carlson MD, et al. Skilled nursing facility referral and hospital readmission rates after heart failure or myocardial infarction. Am J Med. 2012;125(1):100.e1–9.CrossRef
4.
Chen J, Normand SL, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for medicare beneficiaries, 1998-2008. JAMA. 2011;306(15):1669–78.PubMedCentralPubMedCrossRef
5.
Madigan EA, Gordon NH, Fortinsky RH, Koroukian SM, Pina I, Riggs JS. Rehospitalization in a national population of home health care patients with heart failure. Health Serv Res. 2012;47(6):2316–38.PubMedCentralPubMedCrossRef
6.
Chun S, Tu JV, Wijeysundera HC, et al. Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Heart Fail. 2012;5(4):414–21.PubMedCrossRef
7.
Au AG, McAlister FA, Bakal JA, Ezekowitz J, Kaul P, van Walraven C. Predicting the risk of unplanned readmission or death within 30 days of discharge after a heart failure hospitalization. Am Heart J. 2012;164(3):365–72.PubMedCrossRef
8.
Bernheim SM, Grady JN, Lin Z, et al. National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. update on publicly reported outcomes measures based on the 2010 release. Circ Cardiovasc Qual Outcomes. 2010;3(5):459–67.PubMedCentralPubMedCrossRef
9.
Centers for Medicare & Medicaid Services (CMS), HHS. Medicare program; hospital inpatient value-based purchasing program. Final rule. Fed Regist. 2011;76(88):26490–547.
10.
Centers for Medicare and Medicaid Services (CMS), HHS. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and FY 2012 rates; hospitals' FTE resident caps for graduate medical education payment. Final rules. Fed Regist. 2011;76(160):51476–846.
11.
Krumholz HM, Lin Z, Keenan PS, et al. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA. 2013;309(6):587–93.PubMedCentralPubMedCrossRef
12.
Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the medicare fee-for-service program. N Engl J Med. 2009;360(14):1418–28.PubMedCrossRef
13.
Amarasingham R, Moore BJ, Tabak YP, et al. An automated model to identify heart failure patients at risk for 30-day readmission or death using electronic medical record data. Med Care. 2010;48(11):981–8.PubMedCrossRef
14.
Krumholz HM, Chen YT, Wang Y, Vaccarino V, Radford MJ, Horwitz RI. Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J. 2000;139(1 Pt 1):72–7.PubMedCrossRef
15.
16.
Beloin-Jubinville B, Joly-Mischlich T, Rouleau ED, et al. Does hospitalization influence patients' medication adherence and community pharmacists' interventions? Ann Pharmacother. 2013;47(9):1143–52.PubMed
17.
Smaha LA, American Heart Association. The american heart association get with the guidelines program. Am Heart J. 2004;148(5 Suppl):S46–8.PubMedCrossRef
18.
19.
Heidenreich PA, Lewis WR, LaBresh KA, Schwamm LH, Fonarow GC. Hospital performance recognition with the get with the guidelines program and mortality for acute myocardial infarction and heart failure. Am Heart J. 2009;158(4):546–53.PubMedCrossRef
20.
Boutwell AE, Johnson MB, Rutherford P, et al. An early look at a four-state initiative to reduce avoidable hospital readmissions. Health Aff (Millwood). 2011;30(7):1272–80.CrossRef
21.•
Bradley EH, Curry L, Horwitz LI, et al. Hospital strategies associated with 30-day readmission rates for patients with heart failure. Circ Cardiovasc Qual Outcomes. 2013;6(4):444–50. This survey data-based analysis shows the most effective hospital strategies for readmission reduction.
22.
Jack BW, Chetty VK, Anthony D, et al. A reengineered hospital discharge program to decrease rehospitalization: a randomized trial. Ann Intern Med. 2009;150(3):178–87.PubMedCentralPubMedCrossRef
23.
Hansen LO, Greenwald JL, Budnitz T, et al. Project BOOST: effectiveness of a multihospital effort to reduce rehospitalization. J Hosp Med. 2013;8(8):421–7.PubMedCrossRef
24.
Davidson PM, Cockburn J, Newton PJ. Unmet needs following hospitalization with heart failure: implications for clinical assessment and program planning. J Cardiovasc Nurs. 2008;23(6):541–6.PubMedCrossRef
25.
Coleman EA, Parry C, Chalmers S, Min SJ. The care transitions intervention: results of a randomized controlled trial. Arch Intern Med. 2006;166(17):1822–8.PubMedCrossRef
26.
Coleman EA, Smith JD, Raha D, Min SJ. Posthospital medication discrepancies: prevalence and contributing factors. Arch Intern Med. 2005;165(16):1842–7.PubMedCrossRef
27.
Hersh AM, Masoudi FA, Allen LA. Postdischarge environment following heart failure hospitalization: expanding the view of hospital readmission. J Am Heart Assoc. 2013;2(2):e000116.PubMedCentralPubMedCrossRef
28.
Coleman E. Aspen transitional care conference proceedings. 2002.
29.
Naylor MD, Aiken LH, Kurtzman ET, Olds DM, Hirschman KB. The care span: the importance of transitional care in achieving health reform. Health Aff (Millwood). 2011;30(4):746–54.CrossRef
30.
Amarasingham R, Patel PC, Toto K, et al. Allocating scarce resources in real-time to reduce heart failure readmissions: a prospective, controlled study. BMJ Qual Saf. 2013;22(12):998–1005.PubMedCentralPubMedCrossRef
31.
Shepperd S, McClaran J, Phillips CO, et al. Discharge planning from hospital to home. Cochrane Database Syst Rev. 2010;1, CD000313.PubMed
32.
Hansen LO, Young RS, Hinami K, Leung A, Williams MV. Interventions to reduce 30-day rehospitalization: a systematic review. Ann Intern Med. 2011;155(8):520–8.PubMedCrossRef
33.
Fonarow GC. Heart failure disease management programs: not a class effect. Circulation. 2004;110(23):3506–8.PubMedCrossRef
34.
Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol. 1997;30(3):725–32.PubMedCrossRef
35.
West JA, Miller NH, Parker KM, et al. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol. 1997;79(1):58–63.PubMedCrossRef
36.
Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333(18):1190–5.PubMedCrossRef
37.
Galbreath AD, Krasuski RA, Smith B, et al. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation. 2004;110(23):3518–26.PubMedCrossRef
38.
Faxon DP, Schwamm LH, Pasternak RC, et al. Improving quality of care through disease management: principles and recommendations from the American heart association's expert panel on disease management. Circulation. 2004;109(21):2651–4.PubMedCrossRef
39.••
Takeda A, Taylor SJ, Taylor RS, Khan F, Krum H, Underwood M. Clinical service organisation for heart failure. Cochrane Database Syst Rev. 2012;9:CD002752. This Cochrane systematic review reports the impact of HF disease management interventions on readmissions.
40.
Inglis SC, Clark RA, McAlister FA, et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev. 2010;8, CD007228.PubMed
41.•
Burke RE, Coleman EA. Interventions to decrease hospital readmissions: keys for cost-effectiveness. JAMA Intern Med. 2013;173(8):695–8. This article describes five recommended strategies to reduce readmissions and avoid excess cost.
42.
Heart Failure Society of America Guideline Committee. Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Cardiac Fail. 2006;12(1):10–38.CrossRef
43.
Rogers J, Perlic M, Madigan EA. The effect of frontloading visits on patient outcomes. Home Healthc Nurse. 2007;25(2):103–9.PubMedCrossRef
44.
Hernandez AF, Greiner MA, Fonarow GC, et al. Relationship between early physician follow-up and 30-day readmission among medicare beneficiaries hospitalized for heart failure. JAMA. 2010;303(17):1716–22.PubMedCrossRef
45.
Altfeld SJ, Shier GE, Rooney M, et al. Effects of an enhanced discharge planning intervention for hospitalized older adults: a randomized trial. Gerontologist. 2013;53(3):430–40.PubMedCrossRef
46.
Krumholz HM, Amatruda J, Smith GL, et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol. 2002;39(1):83–9.PubMedCrossRef
47.•
Kociol RD, Peterson ED, Hammill BG, et al. National survey of hospital strategies to reduce heart failure readmissions: Findings from the get with the guidelines-heart failure registry. Circ Heart Fail. 2012;5(6):680–7. In this study hospitals participating in the GWTG-HF registries were surveyed to find the strategies associated with lower readmission rates.
48.
Bradley EH, Curry L, Horwitz LI, et al. Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study. J Am Coll Cardiol. 2012;60(7):607–14.PubMedCentralPubMedCrossRef
49.
Whellan DJ, Ousdigian KT, Al-Khatib SM, et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (program to access and review trending information and evaluate correlation to symptoms in patients with heart failure) study. J Am Coll Cardiol. 2010;55(17):1803–10.PubMedCrossRef
50.
van Veldhuisen DJ, Braunschweig F, Conraads V, et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation. 2011;124(16):1719–26.PubMedCrossRef
51.
Whellan DJ, O'Connor CM, Ousdigian KT, Lung TH, PARTNERS HF Study Investigators. Rationale, design, and baseline characteristics of a program to assess and review trending INformation and evaluate CorRelation to symptoms in patients with heart failure (PARTNERS HF). Am Heart J. 2008;156(5):833–9. 839.e2.PubMedCrossRef
52.
Bourge RC, Abraham WT, Adamson PB, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol. 2008;51(11):1073–9.PubMedCrossRef
53.
Adamson PB, Conti JB, Smith AL, et al. Reducing events in patients with chronic heart failure (REDUCEhf ) study design: continuous hemodynamic monitoring with an implantable defibrillator. Clin Cardiol. 2007;30(11):567–75.PubMedCrossRef
54.
Abraham WT, Adamson PB, Hasan A, et al. Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure. Am Heart J. 2011;161(3):558–66.PubMedCrossRef
55.
Ouslander JG, Diaz S, Hain D, Tappen R. Frequency and diagnoses associated with 7- and 30-day readmission of skilled nursing facility patients to a nonteaching community hospital. J Am Med Dir Assoc. 2011;12(3):195–203.PubMedCrossRef
Metadata
Title
Interventions for Heart Failure Readmissions: Successes and Failures
Authors
Lisa M. Fleming
Robb D. Kociol
Publication date
01-06-2014
Publisher
Springer US
Published in
Current Heart Failure Reports / Issue 2/2014
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-014-0192-x

Other articles of this Issue 2/2014

Current Heart Failure Reports 2/2014 Go to the issue

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section Editor)

Interleukin-6 Signaling, Soluble Glycoprotein 130, and Inflammation in Heart Failure

HOT TOPIC

Ethical Challenges of Deactivation of Cardiac Devices in Advanced Heart Failure

Management of Heart Failure (TE Meyer, Section Editor)

Polypharmacy in Heart Failure Patients

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section Editor)

Neuregulin-1 Signaling in the Pathogenesis of Chemotherapy-Induced Heart Failure

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section Editor)

Heart Failure and Obesity in Adults: Pathophysiology, Clinical Manifestations and Management

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section Editor)

Pathophysiology and Potential Clinical Applications for Testing of Peripheral Chemosensitivity in Heart Failure
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits